title: Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent cushing's syndrome.
abstract: Gastric inhibitory polypeptide (GIP)-dependent Cushing's syndrome has been reported to occur either in unilateral adrenal adenoma or in bilateral macronodular adrenal hyperplasia. A 33-yr-old woman with Cushing's syndrome was found to have two 2.5- to 3-cm nodules in the right adrenal on computed tomography scan; the left adrenal appeared normal except for the presence of a small 0.8 x 0.6-cm nodule. Uptake of iodocholesterol was limited to the right adrenal. Plasma morning cortisol was 279 nmol/L fasting and 991 nmol/L postprandially, and ACTH remained suppressed. Plasma cortisol increased after oral glucose (202%) or a lipid-rich meal (183%), but not after a protein-rich meal (95%) or iv glucose (93%); the response to oral glucose was blunted by pretreatment with 100 microg octreotide, sc. Plasma cortisol and GIP levels were positively correlated (r = 0.95; P = 0.0001); cortisol was stimulated by the administration of human GIP iv (225%), but not by GLP-1, insulin, TRH, GnRH, glucagon, arginine vasopressin, upright posture, or cisapride orally. A right adrenalectomy was performed; GIP receptor messenger ribonucleic acid was overexpressed in both adrenal nodules and in the adjacent cortex. Histopathology revealed diffuse macronodular adrenal hyperplasia without internodular atrophy. Three months after surgery, fasting plasma ACTH and cortisol were suppressed, but cortisol increased 3.6-fold after oral glucose, whereas ACTH remained suppressed; this was inhibited by octreotide pretreatment, suggesting that cortisol secretion by the left adrenal is also GIP dependent. We conclude that GIP-dependent nodular hyperplasia can progress in an asynchronous manner and that GIPR overexpression is an early event in this syndrome.
authors.affiliation: Department of Medicine, Research Center, Hôtel-Dieu, Centre Hospitalier de l'Université de Montréal, Saint-Ubain, Canada.
authors.forename: N
authors.initials: N
authors.lastname: N'Diaye
authors.forename: P
authors.initials: P
authors.lastname: Hamet
authors.forename: J
authors.initials: J
authors.lastname: Tremblay
authors.forename: J M
authors.initials: JM
authors.lastname: Boutin
authors.forename: L
authors.initials: L
authors.lastname: Gaboury
authors.forename: A
authors.initials: A
authors.lastname: Lacroix
mesh_terms: D000311:Adrenal Glands / Q000473:pathology*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D003480:Cushing Syndrome / Q000473:pathology*; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000502:physiology*; D006801:Humans; D006965:Hyperplasia; D012333:RNA, Messenger / Q000032:analysis; D011964:Receptors, Gastrointestinal Hormone / Q000235:genetics
chemical_list: D012333:RNA, Messenger; D011964:Receptors, Gastrointestinal Hormone; D005749:Gastric Inhibitory Polypeptide; D000324:Adrenocorticotropic Hormone; C041086:gastric inhibitory polypeptide receptor